Form 4: Cutera Inc. Director Jeryl L. Hilleman Reports Stock Option Grant

Director Jeryl L. Hilleman reports the acquisition of stock options in Cutera Inc.

Summary

• On October 24, 2024, Jeryl L. Hilleman, a director of Cutera Inc., reported the acquisition of 14,673 stock options.
• The options have an exercise price of $0.65.
• The options vest on the earlier of 12 months from the grant date or the day of the 2025 annual stockholder meeting, contingent upon continued service with the company.
• The options expire on October 23, 2031, but may expire earlier if Hilleman's service with the company terminates.
• Following the transaction, Hilleman beneficially owns 40,000 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock option grants, which is neither inherently positive nor negative. The sentiment is neutral.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service with the company.

Risks

• The value of the stock options is dependent on the future performance of Cutera Inc.'s stock.
• The options may expire worthless if the stock price does not exceed the exercise price.

Industry Context

Stock option grants are a common form of executive compensation in the technology and healthcare industries, used to incentivize performance and align management interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies.
• The vesting schedule and expiration date are typical for such grants.
• The specific number of options granted and the exercise price would be benchmarked against similar companies in the medical device industry to assess competitiveness.

Stakeholder Impact

• The stock option grant could potentially impact shareholders by diluting ownership if the options are exercised.
• The grant incentivizes the director to work towards increasing shareholder value.

Key Dates

Keywords

stock options, director, Cutera Inc., CUTR, beneficial ownership, Form 4, insider trading